Findings from the researchers’ study of the safety and efficacy of the vaccine were published this week in a peer-reviewed journal. Phase 2 trials are underway.
The new funding, through the Canadian Pandemic Preparedness Hub, supports the Fitzhenry Vector Lab and the Sartorius Bioprocess Automation Lab.
The Future of Vaccinology Symposium was hosted by McMaster’s Global Nexus School for Pandemic Prevention & Response and the Michael G. DeGroote Institute for Infectious Disease Research.
McMaster logo
McMaster logo
